Navigation Links
Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007

MINNEAPOLIS, May 23, 2007 (BUSINESS WIRE) -- MGI PHARMA, INC. (NASDAQ:MOGN), a biopharmaceutical company focused in oncology and acute care, today announced the presentation of results of a successful pivotal phase 3 trial of Aquavan(R) (fospropofol disodium) Injection in patients undergoing colonoscopy. Primary and secondary efficacy endpoint results, as well as safety data, were presented at Digestive Disease Week 2007 in Washington, D.C. by Lawrence B. Cohen, MD, Department of Medicine/ Gastroenterology, Mount Sinai School of Medicine, New York.

Aquavan Injection is a proprietary water-soluble prodrug of propofol that is in clinical development for moderate sedation of patients undergoing therapeutic and diagnostic procedures. Aquavan has not yet been approved for marketing by the U.S. Food and Drug Administration (U.S. FDA) or any other regulatory agencies.

"Aquavan has a favorable pharmacokinetic profile, making it possible to deliver a predictable concentration of sedative and achieve the desired level of sedation," said Dr. Cohen, a lead investigator of the trial.

Colonoscopy Results: Primary Endpoint of Sedation Success Achieved (Abstract W1451)

A randomized, double-blind, multi-center phase 3 pivotal trial was conducted to evaluate whether an Aquavan dosing regimen of 6.5 mg/kg would be safe and effective in providing moderate sedation in patients undergoing colonoscopy, compared to a 2.0 mg/kg Aquavan regimen. A total of 312 patients in 18 sites were pre-treated with fentanyl citrate (50 (mu)g) and then received either Aquavan 2.0 mg/kg, Aquavan 6.5 mg/kg or midazolam 0.02 mg/kg (2:3:1 ratio). Gastroenterologists administered the sedatives, as is consistent with a large percentage of routine colonoscopies. Patients were ages 18 and older and in varying states of health and sedation risk.

The results showed that 87% of patients who received an initial bolus dose
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study of Aquavan Injection in Patients Undergoing Bronchoscopy
2. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
3. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
4. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
5. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
6. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
7. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
8. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
9. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
10. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:7/28/2014)... VALLEY, Pa. , July 28, 2014  Air ... reliable, uninterrupted supply of medical oxygen is vital to ... to technical innovations that not only improve the efficiency ... use. Air Products will highlight these systems—including systems for ... that reduce oxygen loss—from August 4-5 at the ...
(Date:7/28/2014)... , July 28, 2014 Southern Research ... , Ph.D., President and CEO of Southern Research ... Release Society (CRS) for the 2014-2015 term.  The ... on July 12 in Chicago ... The Controlled Release Society is ...
(Date:7/28/2014)... , July 28, 2014  A prospective study ... Sweden has validated the performance of ... and has associated volumetrically assessed breast density measurements ... Epidemiology, Biomarkers & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the ... tool for widespread breast cancer risk assessment," was ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4
(Date:7/28/2014)... July 28, 2014 Shofner Vision ... Military June . Renowned LASIK and Cataract Surgeon, ... provide significant funds and public awareness for local ... military personnel and their families. “This was our ... give nearly $5,000 to a variety of local ...
(Date:7/28/2014)... more chronic medical conditions people have at retirement age, ... study claims. Since nearly four in five ... Hopkins Bloomberg School of Public Health in Baltimore said ... expectancy are slowing in the United States. "Living ... and heart failure is now the norm and not ...
(Date:7/28/2014)... DC (PRWEB) July 28, 2014 SIMpalm ... app for iOS, App is available on iTunes for ... of its kind, Audio Chef allows you to listen and ... cuisine the easy way: simply get out the ingredients and ... need to measure or prepare ingredients ahead of time, just ...
(Date:7/28/2014)... Lake City, Utah (PRWEB) July 28, 2014 ... protein powders and drinks, announced that it will be ... drink line of products this summer. The additional flavors ... with clean pure taste-free protein , Inspire Pomegranate Razz ... Vanilla - flavor of soft-serve vanilla cone , Bariatric ...
(Date:7/28/2014)... Camden, NJ (PRWEB) July 28, 2014 ... to provide enhanced access and reduced wait times for ... only six hospital systems in the state—and the only ... HealthNet Federal Services Patient-Centered Community Care program (PC3). PC3 ... Veterans Administration (VA) hospital cannot provide services due to ...
Breaking Medicine News(10 mins):Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3Health News:Chronic Medical Conditions Can Shorten Seniors' Lives: Study 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Bariatric Eating Announces Three New Protein Shake Flavors 2Health News:Lourdes Expands Military Partnership with Veterans 2Health News:Lourdes Expands Military Partnership with Veterans 3
... can be made from some of the same parts ... developed a way to measure the growth and drug ... a microscope. The new biosensor promises to speed ... the Richard Smalley Distinguished University Professor of Chemistry, Physics ...
... Thea Friedman, M.D., associate scientist and director of oncology ... Hackensack University Medical Center was recently awarded a National ... research grant to improve allogeneic blood and marrow transplantation ... million in funding over the next five years. ...
... Boston, Mass. Following a successful Phase 1 study ... Massachusetts Medical School (UMMS) today announced the beginning of ... a human monoclonal antibody they developed to prevent ... in transplant patients. The first patients were enrolled ...
... 18 January 2011 - A recent study by Merikangas ... the Journal of the American Academy of Child ... of adolescents that are affected with severely impairing mental ... The researchers found that approximately one third of adolescents ...
... have used a type of brain scanning, known as functional ... blood flow in the brain and to correlate this with ... which could improve is reported in the International Journal ... known since the 1890s that changes in blood flow and ...
... for breast cancer are well studied and documented. Thus, scientists ... onset of menopause and a family history of breast cancer ... neither an individual woman nor medicine can influence whether family ... - these are risk factors on which we have no ...
Cached Medicine News:Health News:See how they grow: Monitoring single bacteria without a microscope 2Health News:See how they grow: Monitoring single bacteria without a microscope 3Health News:Oncology basic research director at John Theurer Cancer Center continues transplantation research 2Health News:First liver transplant patients receive experimental drug to prevent hepatitis C infection 2Health News:First liver transplant patients receive experimental drug to prevent hepatitis C infection 3Health News:Adolescents with severe mental disorders have never received treatment 2Health News:Functional boost for magnetic resonance imaging 2Health News:Scientists identify avoidable breast cancer risk factors 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: